Viemed Healthcare (VMD) Non-Current Debt (2019 - 2026)
Viemed Healthcare (VMD) posted Non-Current Debt of $8.3 million for Q1 2026, down 26.19% on a QoQ basis from $11.3 million in Q4 2025, and up 136.09% year-over-year from $3.5 million in Q1 2025.
Viemed Healthcare (VMD) Non-Current Debt (2019 - 2026) Analysis & Trends
Viemed Healthcare's Non-Current Debt history runs 8 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- Quarterly Non-Current Debt rose 136.09% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (up 136.09% YoY) and the FY2025 annual result came in at $11.3 million, up 214.6% from the prior year.
- Non-Current Debt was $8.3 million for Q1 2026 at Viemed Healthcare, down from $11.3 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $19.6 million in Q3 2025 and bottomed at $3.5 million in Q2 2025.
- A 5-year average of $7.1 million and a median of $5.9 million in 2024 frame the typical range for Non-Current Debt.
- Peak annual rise in Non-Current Debt reached 436.58% in 2025, while the deepest fall reached 60.24% in 2025.
- Viemed Healthcare's Non-Current Debt stood at $4.2 million in 2022, then soared by 44.42% to $6.0 million in 2023, then tumbled by 40.2% to $3.6 million in 2024, then surged by 214.6% to $11.3 million in 2025, then decreased by 26.19% to $8.3 million in 2026.
- Business Quant data shows VMD's Non-Current Debt at $8.3 million in Q1 2026, $11.3 million in Q4 2025, and $19.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 8.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.33 Mn |
| Dec 31, 2025 | 11.29 Mn |
| Sep 30, 2025 | 19.59 Mn |
| Jun 30, 2025 | 3.47 Mn |
| Mar 31, 2025 | 3.53 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Sep 30, 2024 | 3.65 Mn |
| Jun 30, 2024 | 8.72 Mn |
| Mar 31, 2024 | 5.91 Mn |
| Dec 31, 2023 | 6.00 Mn |
| Sep 30, 2023 | 8.10 Mn |
| Jun 30, 2023 | 12.11 Mn |
| Sep 30, 2022 | 4.16 Mn |
| Jun 30, 2022 | 4.23 Mn |
| Mar 31, 2022 | 4.27 Mn |
| Dec 31, 2021 | 4.31 Mn |
| Sep 30, 2021 | 4.35 Mn |
| Jun 30, 2021 | 4.85 Mn |
| Mar 31, 2021 | 5.32 Mn |
| Dec 31, 2020 | 5.80 Mn |